Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $142.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 8.06% to $142.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $142.1 million, a 8.06% increase, with the full-year FY2025 number at $142.1 million, up 8.06% from a year prior.
  • Total Non-Current Liabilities was $142.1 million for Q4 2025 at PROCEPT BioRobotics, up from $130.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $142.1 million in Q4 2025 to a low of $68.0 million in Q1 2022.
  • A 5-year average of $110.6 million and a median of $119.1 million in 2023 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: soared 63.48% in 2023, then fell 1.33% in 2025.
  • PROCEPT BioRobotics' Total Non-Current Liabilities stood at $69.7 million in 2021, then surged by 58.43% to $110.5 million in 2022, then increased by 11.74% to $123.4 million in 2023, then increased by 6.5% to $131.5 million in 2024, then increased by 8.06% to $142.1 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Total Non-Current Liabilities are $142.1 million (Q4 2025), $130.7 million (Q3 2025), and $127.0 million (Q2 2025).